DuPont Adds New Alginate-Based Excipient to Pharma Portfolio

September 23, 2014
Pharmaceutical Technology Editors

DuPont Nutrition & Health has added a new pharmaceutical excipient to the portfolio of ingredients for CPhI Worldwide 2014, in Paris this October.

DuPont Nutrition & Health has added a new pharmaceutical excipient to the portfolio of ingredients for CPhI Worldwide 2014, in Paris this October. The company will be exhibiting in hall 5, stand no. 5C89.

Alginate Pharma Grade is the first in a new series of alginate-based excipients developed to ensure the active ingredients in medicinal tablets reach their biological target intact and are released on time. DuPont’s pharma portfolio consists of excipients as well as actives. Production is based at the DuPont plant in Landerneau, France, where the French National Authority for Medicines and Health Products Safety has approved the dedicated production line.

“We have documented the Alginate Pharma Grade in a series of trials and expect to launch additional pharma-grade alginates for specific applications in the near future. Samples are available for functionality testing,” says Peter Janetzky, sales manager, Pharma & Industrials, DuPont Nutrition & Health, in a press statement.

Source: DuPont